Get an alert when COSTELLO MEDICAL CONSULTING LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£8.5M

Latest balance sheet

Net assets

£13M

Equity attributable

Employees

386

Average over period

Profit before tax

£4.9M

Period ending 2023-12-31

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

1-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-31 Δ vs prior
Turnover £36,034,928
Operating profit £4,816,386
Profit before tax £4,943,853
Net profit £3,796,187
Cash £8,548,958
Total assets less current liabilities £13,405,289
Net assets £12,877,938
Equity £12,877,938
Average employees 386
Wages £20,319,378
Directors' remuneration £15,816

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . Year-on-year comparison hidden: this filing's period length differs materially from the prior year. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-31
Operating margin 13.4%
Net margin 10.5%
Return on capital employed 35.9%
Current ratio 1.88x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
PEM Audit Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent Company's ability to continue as a going concern for a period of at least twelve months from when the Financial Statements are authorised for issue.”

Group structure

  1. COSTELLO MEDICAL CONSULTING LIMITED · parent
    1. Costello Medical Singapore PTE. Ltd 82% · Singapore
    2. Costello Medical Inc 100% · USA
    3. Costello Medical Shanghai 100% · China
    4. Costello Medical Canada Inc. 100% · Canada

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 1 resigned

Name Role Appointed Born Nationality
SHORT, Richard Graham Secretary 2008-11-11 British
COSTELLO, Sophie Director 2008-11-11 Apr 1978 British
DARVELL, Michael John Director 2026-06-18 Mar 1977 British
SHORT, Richard Graham Director 2008-11-11 Apr 1976 British
Show 1 resigned officer
Name Role Appointed Resigned
COSTELLO, Helene Director 2019-05-20 2026-05-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Costello Medical Global Limited Corporate entity Shares 75–100%, Voting 75–100% 2026-02-10 Active
Mr Richard Graham Short Individual Shares 75–100% (as firm), Voting 75–100% (as firm) 2016-04-06 Ceased 2026-02-12
Ms Sophie Costello Individual Shares 75–100% (as firm), Voting 75–100% (as firm) 2016-04-06 Ceased 2026-02-12

Filing timeline

Last 20 of 82 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2026-06-26 MA Memorandum articles
  • 2026-06-26 RESOLUTIONS Resolution
Date Type Category Description
2026-06-26 SH08 capital Capital name of class of shares
2026-06-26 MA incorporation Memorandum articles
2026-06-26 RESOLUTIONS resolution Resolution
2026-06-20 AP01 officers Appoint person director company with name date PDF
2026-06-07 AA accounts Accounts with accounts type group
2026-06-06 TM01 officers Termination director company with name termination date PDF
2026-05-23 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2026-05-23 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2026-02-14 SH08 capital Capital name of class of shares
2026-02-12 PSC04 persons-with-significant-control Change to a person with significant control PDF
2026-02-12 PSC04 persons-with-significant-control Change to a person with significant control PDF
2026-02-12 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2025-11-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-23 AA accounts Accounts with accounts type group
2024-11-25 CS01 confirmation-statement Confirmation statement with updates PDF
2024-09-03 SH08 capital Capital name of class of shares
2024-06-13 AA accounts Accounts with accounts type group
2023-11-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-05-25 AA accounts Accounts with accounts type group
2022-11-23 CS01 confirmation-statement Confirmation statement with updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
14

last 12 months

Capital events
3

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page